GLAXOSMITHKLINE UK LIMITED

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2026	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierGLAXOSMITHKLINE UK LIMITED

At-a-glance view of the first 2 buyers in the ranked list below.

NHS England3 awards · no published value assigned · 3 values excluded
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Source records

Published awards

4 records linked to this supplier.

Meningitis B Vaccine (2026)
Buyer: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
End date in notice
30 Sept 2029Date from the linked contract
Value shown in notice
£1Value from the linked contract
Official source
Open the official Find a Tender notice for Meningitis B Vaccine (2026)
About this figure
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
ocds-h6vhtk-059678 / 2
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
Buyer: NHS England
End date in notice
31 Aug 2028Date from the linked contract
Value shown in notice
£813,863,584Value from the linked contract

GLAXOSMITHKLINE UK LIMITED

Published records by year

Buyer relationships by value counted

Published awards

Meningitis B Vaccine (2026)

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products